Last reviewed · How we verify
Fisiogen Ferro Forte
Fisiogen Ferro Forte is a Iron supplement Small molecule drug developed by Hospital Universitari Vall d'Hebron Research Institute. It is currently FDA-approved for Iron deficiency anemia. Also known as: Oral treatment with liposomated iron (Fisiogen Ferro Forte).
Fisiogen Ferro Forte is an iron supplement that replenishes iron stores to treat or prevent iron deficiency anemia.
Fisiogen Ferro Forte is a small molecule used in parenteral iron therapy, specifically studied in the context of liposomated iron and its effectiveness after bariatric surgery. It has been compared to Venofer in clinical trials for this purpose.
At a glance
| Generic name | Fisiogen Ferro Forte |
|---|---|
| Also known as | Oral treatment with liposomated iron (Fisiogen Ferro Forte) |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute |
| Drug class | Iron supplement |
| Target | Iron (Fe2+/Fe3+) |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Mechanism of action
The product contains iron in a formulated delivery system designed to improve bioavailability and gastrointestinal tolerance. Iron is an essential mineral required for hemoglobin synthesis and oxygen transport in red blood cells. By restoring adequate iron levels, the drug enables normal erythropoiesis and reverses anemia-related symptoms.
Approved indications
- Iron deficiency anemia
Common side effects
- Gastrointestinal disturbance (nausea, constipation, abdominal discomfort)
- Dark stools
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fisiogen Ferro Forte CI brief — competitive landscape report
- Fisiogen Ferro Forte updates RSS · CI watch RSS
- Hospital Universitari Vall d'Hebron Research Institute portfolio CI
Frequently asked questions about Fisiogen Ferro Forte
What is Fisiogen Ferro Forte?
How does Fisiogen Ferro Forte work?
What is Fisiogen Ferro Forte used for?
Who makes Fisiogen Ferro Forte?
Is Fisiogen Ferro Forte also known as anything else?
What drug class is Fisiogen Ferro Forte in?
What development phase is Fisiogen Ferro Forte in?
What are the side effects of Fisiogen Ferro Forte?
What does Fisiogen Ferro Forte target?
Related
- Drug class: All Iron supplement drugs
- Target: All drugs targeting Iron (Fe2+/Fe3+)
- Manufacturer: Hospital Universitari Vall d'Hebron Research Institute — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Iron deficiency anemia
- Also known as: Oral treatment with liposomated iron (Fisiogen Ferro Forte)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing